Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT. Ali H, Salhotra A, Stein AS, Nakamura R, et al. Leuk Res 2021;104:106579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ali H, Salhotra A, Stein AS, Nakamura R, et al. Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT. Leuk Res 2021;104:106579.
PMID: 33831656